Efficacy and safety of transarterial chemoembolization (TACE) in combination with tislelizumab and TKIs versus TACE for the treatment of Intermediate and advanced HCC: A retrospective cohort study

被引：0
|
作者：
Han, Y. [1 ]
Tang, S. [1 ]
Gao, Y. [1 ]
Yan, X. [1 ]
Zhi, W. [1 ]
Gong, T. [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Intervent Therapy, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
240P
引用
收藏
页码：S1494 / S1494
页数：1
相关论文
共 50 条
  • [21] Combined Transarterial Chemoembolization (TACE) and Percutaneous Local Ablation Therapy for Advanced Hepatocellular Carcinoma (HCC)
    Kirikoshi, Hiroyuki
    Saito, Satoru
    Yoneda, Masato
    Fujita, Koji
    Mawatari, Hironori
    Nozaki, Yuichi
    Suzuki, Kaori
    Endo, Hiroki
    Takahashi, Hirokazu
    Abe, Yasunobu
    Inamori, Masahiko
    Kobayashi, Noritoshi
    Kubota, Kensuke
    Nakajima, Atsushi
    GASTROENTEROLOGY, 2010, 138 (05) : S809 - S810
  • [22] Combination of transarterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) compared to TACE alone as bridging therapy transplant recipients with hepatocellular carcinoma: An update.
    Esmail, Abdullah
    Victor, David
    Kodali, Sudha
    Graviss, Edward A.
    Nguyen, Duc T.
    Moore, Linda W.
    Saharia, Ashish
    McMillan, Robert
    Fong, Joy N.
    Uosef, Ahmed
    Elshawwaf, Mahmoud
    Heyne, Kirk
    Ghobrial, Rafik Mark
    Abdelrahim, Maen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16201 - E16201
  • [23] The outcome of combination of transarterial chemoembolization (TACE) and percutancous ethanol injection (PEI) therapies for hepatocellular carcinoma (HCC)
    Kirikoshi, Hiroyuki
    Yoneda, Masato
    Fujita, Koji
    Saito, Satoru
    Nakajima, Atsushi
    GASTROENTEROLOGY, 2006, 130 (04) : A776 - A777
  • [24] A PILOT STUDY OF NEOADJUVANT TRANSARTERIAL CHEMOEMBOLIZATION (TACE) FOR LOCALLY ADVANCED CERVICAL ADENOCARCINOMA
    Tsubamoto, H.
    Aoki, M.
    Hosoda, Y.
    Kanazawa, R.
    Komori, S.
    Koyama, K.
    Maeda, H.
    Hirota, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 213 - 214
  • [25] Transarterial chemoembolization (TACE) plus lenvatinib versus TACE plus sorafenib for hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT): A prospective randomized study
    Ding, X.
    Sun, W.
    Chen, J.
    Li, W.
    Shen, Y.
    Guo, X.
    Teng, Y.
    Liu, X.
    Li, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S1306 - S1306
  • [26] Transarterial chemoembolization (TACE) with degradable starch microspheres (DSM) in hepatocellular carcinoma (HCC): multi-center results on safety and efficacy
    Schicho, Andreas
    Pereira, Philippe L.
    Haimerl, Michael
    Niessen, Christoph
    Michalik, Katharina
    Beyer, Lukas P.
    Stroszczynski, Christian
    Wiggermann, Philipp
    ONCOTARGET, 2017, 8 (42) : 72613 - 72620
  • [27] Sunitinib and Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma (HCC)- Final Results of a Phase 2 Trial
    Iyer, R.
    Fetterly, G.
    Groman, A.
    Hutson, A.
    Khushalani, N.
    Mohile, S.
    Ashton, E.
    Litwin, A.
    Grande, C.
    Tomaszewski, G.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S447 - S447
  • [28] Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE)
    Fernandez-Palanca, Paula
    Mauriz, Jose L.
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (02)
  • [29] Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study
    Ren, Baosheng
    Wang, Wansheng
    Shen, Jian
    Li, Wanci
    Ni, Caifang
    Zhu, Xiaoli
    JOURNAL OF CANCER, 2019, 10 (05): : 1189 - 1196
  • [30] Efficacy of Combination Therapy (in Addition to Sorafenib) in hepatocellular Carcinoma (HCC) after Progress under local Tumor Therapy by transarterial Chemoembolization (TACE)
    Johanniemann, K.
    Werner, T.
    Breitfeld, P.
    Lohse, A.
    Koops, A.
    Wege, H.
    INTERNIST, 2013, 54 : 31 - 31
12345